"We found that being treated at an academic center was associated with improved survival, suggesting that specialized care for CMML is an important aspect of treatment." — Douglas Tremblay, MD, Tisch ...

– Complete remission (CR) rate of 50% and overall response rate (ORR) of 66.7% in 18 evaluable patients with CMML treated with IO-202 in combination with azacitidine – – CR rate of 83.3% and ORR of ...

Symptoms of chronic myelomonocytic leukemia (CMML) can include tiredness, bruising and bleeding easily, frequent infections, sweating, and bone pain. Symptoms can depend on the type of CMML. Chronic ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), today announced the first patient was dosed with lenzilumab in the Precision Approach to Chronic Myelomonocytic ...

Chronic myeloid leukemia (CML) and chronic myelomonocytic leukemia (CMML) are two different types of cancer that affect the blood and bone marrow. In people with CML, the body creates abnormal white ...

The prognostic impact of monocytosis in patients with myelodysplastic syndromes (MDS) is not well-studied and not been clearly defined. Patients with MDS and monocytosis had a shorter overall survival ...

Mike and Sofia Segal, who immigrated to the U.S. from present-day Ukraine in 1978, lead foundation that supports overlooked and underfunded causes, including rare diseases RYE BROOK, N.Y., Oct. 25, ...